Artiva Biotherapeutics to Attend Healthcare Conference

The biotech company will participate in the 25th Annual Needham Virtual Healthcare Conference.

Apr. 8, 2026 at 1:42pm

Got story updates? Submit your updates here. ›

Artiva Biotherapeutics, a San Diego-based biotech company, has announced that it will be participating in the 25th Annual Needham Virtual Healthcare Conference. The conference is a major industry event that brings together healthcare companies and investors.

Why it matters

Artiva's participation in this high-profile conference signals that the company is actively engaged with the broader healthcare investment community. As a publicly traded biotech firm, Artiva's presence at the event could help raise its profile and potentially attract new investors or partners.

The details

Artiva Biotherapeutics is a clinical-stage biotech company focused on developing innovative cell therapies to treat cancer. The company's lead product candidate is currently in Phase 2 clinical trials. Participation in the Needham conference will allow Artiva to showcase its pipeline and share updates on its research and development efforts with the investment community.

  • The 25th Annual Needham Virtual Healthcare Conference is scheduled for April 8-11, 2026.

The players

Artiva Biotherapeutics, Inc.

A clinical-stage biotech company focused on developing innovative cell therapies to treat cancer.

Got photos? Submit your photos here. ›

The takeaway

Artiva's participation in the prestigious Needham Healthcare Conference demonstrates the company's commitment to engaging with the investment community and advancing its pipeline of cancer-fighting cell therapies.